Professional Information
Dr. Claudia
Dovali Solis
Global Program Team head Pediatric and Specialty Vaccines
Novartis Vaccines and Diagnostics
Pharmaceuticals
Education, Honors & Awards
Universidad Nacional Autónoma de México; University of Cambridge; Henley Management College
General Surgeon MD, Medicine, Medical Doctor, Universidad Nacional Autónoma de México; Degree in Management, University of Cambridge; Master of Business Administration (MBA), MBA & Advance Management Subjects, First Year Completed, Henley Management College; ADVAC, Advance Course of Vaccinology, Vaccines, Completion 60 European CME credits; ADVAC, Advance Course of Vaccinology, Vaccines, Completion 60 European CME credits;M1 leadership, Completion; NVD Development Program
Personal Information
Italy
Sper Tavarnufe
Reader; Traveling
16-20 Years
Dr. Claudia Dovali Solis has 18 years of experience in the full business cycle of the pharmaceutical industry across a broad base of therapeutic areas and market segments at country, region and global level. Dr. Solis' expertise in setting global, regional, country portfolio strategy to drive commercial performance, and P&l management of the organization. Her key strength is in her deep understanding and knowledge of all key levers of the pharma businesses from a commercial, regulatory, operational, technological and scientific perspective. Dr. Solis has proven leadership and general management of high performance functional and operational teams in multicultural settings and matrix organization.
Lead the strategy and operational activities of the cross functional teams across the full range life cycle management of franchises; pipe line development; market operation and partnerships; pediatric primary schedule vaccines; booster vaccines, travel and mature vaccines; emerging diseases
Websites & Social

We're sorry, in order to view this member's profile you must be a member. Please , or apply for membership.

If you're currently a member with us, but this is your first time logging in a while, your password may have changed for security reasons. In order to access the registry, please reset your password, or contact us today.

Follow Us